Fujifilm Diosynth Biotechnologies Expands Its Gene Therapy Manufacturing Capacity at Its College Station, Texas Location
February 29, 2020
February 29, 2020
COLLEGE STATION, Texas, Feb. 29 -- Fujifilm USA issued the following news on Feb. 28:
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and manufacture of their biologics, vaccines and gene therapies has announced that it has commenced the planned capacity expansion of its "Flexible Biomanufacturing Facility" at . . .
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with the development and manufacture of their biologics, vaccines and gene therapies has announced that it has commenced the planned capacity expansion of its "Flexible Biomanufacturing Facility" at . . .